Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
○ Serum Free Light Chains -血清遊離輕鏈 - ☆ 優活 健康網 ☆ Living Well Website
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis | HTML
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis | PLOS ONE
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
TECHNICALREVIEW
Serum Free Light Chain | | Content Tag
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
A multicentre study comparing two methods for serum free light chain analysis - RJ Lock, R Saleem, EG Roberts, MJ Wallage, TJ Pesce, A Rowbottom, SJ Cooper, ED McEvoy, JL Taylor, S
The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains - ScienceDirect
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis | Neurology Neuroimmunology & Neuroinflammation
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink
JaypeeDigital | eBook Reader
PDF) Immunoglobulin Free Light Chain Dimers in Human Diseases
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Freelite® Serum Free Light Chain Assays from Binding Site | SelectScience
![Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13385/1/fig-1-full.png "Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]")
Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
